Published in Neurology on September 01, 1994
The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol (2005) 1.57
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39
Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry (2002) 1.13
Successful treatment of stiff man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry (1997) 0.82
Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects. J Neurol (2006) 0.81
Complex regional pain syndrome treated with intravenous immunoglobulin in a patient with common variable immune deficiency. Pain Ther (2013) 0.75
Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med (1995) 2.96
Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med (1986) 2.22
Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology (1991) 2.16
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2001) 1.88
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol (1989) 1.88
Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology (1999) 1.62
Pupil-sparing oculomotor palsies with internal carotid-posterior communicating artery aneurysms. Ann Neurol (1983) 1.55
Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol (1989) 1.54
Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol (1994) 1.52
Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (1987) 1.36
Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology (2000) 1.31
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology (2007) 1.21
The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol (1985) 1.17
Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology (2003) 1.14
Azathioprine toxicity in neuromuscular disease. Neurology (1986) 1.01
Autonomic impairment in painful neuropathy. Neurology (2001) 1.00
Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion. Neurology (1997) 0.96
Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology (2010) 0.94
Pilot trial of etanercept in the treatment of inclusion-body myositis. Neurology (2006) 0.93
Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology (1995) 0.92
Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Neurol Clin (2001) 0.92
Active site of the enzyme which demethylates receptors during bacterial chemotaxis. J Biol Chem (1987) 0.90
Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology (1999) 0.88
Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology (1994) 0.87
Sustained myoglobinuria: the presenting manifestation of dermatomyositis. Neurology (1996) 0.84
The immunopathogenic role of complement in human muscle disease. Curr Opin Neurol (1996) 0.82
Case-of-the-month: painful thigh mass in a young woman: diabetic muscle infarction. Muscle Nerve (1992) 0.82
A molecular protocol for diagnosing myotonic dystrophy. Clin Chem (1995) 0.81
Idiopathic muscular infarction in a diabetic patient. Report of a case. J Bone Joint Surg Am (1991) 0.80
Magnetic resonance imaging in a case of autopsy-proved adult subacute necrotizing encephalomyelopathy (Leigh's disease). Arch Neurol (1987) 0.80
Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test. Neurology (1985) 0.80
Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res (2001) 0.79
Post-radiation lower motor neuron syndrome. J Clin Neuromuscul Dis (2000) 0.79
Fine-mapping the gene for X-linked myopathy with excessive autophagy. Neurology (2008) 0.78
Scapuloperoneal neuropathy: a distinct clinicopathologic entity. J Neurol Sci (1988) 0.78
Three cases of amyotrophic lateral sclerosis in a common occupational environment. J Neurol (1987) 0.77
Central nervous system involvement in the eosinophilia-myalgia syndrome. Arch Neurol (1992) 0.77
Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial. Neurology (1985) 0.76
Treatment of myasthenia gravis: A call to arms. Neurology (2000) 0.75
Stiff-person syndrome: stiff opposition to a simple explanation. Neurology (1998) 0.75
Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy. Neurology (2007) 0.75
Expression of Schwann cell and peripheral T-cell activation epitopes in hereditary motor and sensory neuropathy. J Neuroimmunol (1992) 0.75
Electrophysiology extends the phenotypic spectrum of X-linked myopathy with excessive autophagy. Neurology (2005) 0.75
Plasma exchange and prednisone in acute inflammatory polyradiculoneuropathy: a controlled randomized trial. J Clin Apher (1985) 0.75